Sporadic inclusion body myositis-derived myotube culture revealed muscle cell-autonomous expression profiles.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 26 02 2024
accepted: 10 06 2024
medline: 1 8 2024
pubmed: 1 8 2024
entrez: 1 8 2024
Statut: epublish

Résumé

Sporadic inclusion body myositis (sIBM) is a muscle disease in older people and is characterized by inflammatory cell invasion into intact muscle fibers and rimmed vacuoles. The pathomechanism of sIBM is not fully elucidated yet, and controversy exists as to whether sIBM is a primary autoimmune disease or a degenerative muscle disease with secondary inflammation. Previously, we established a method of collecting CD56-positive myoblasts from human skeletal muscle biopsy samples. We hypothesized that the myoblasts derived from these patients are useful to see the cell-autonomous pathomechanism of sIBM. With these resources, myoblasts were differentiated into myotubes, and the expression profiles of cell-autonomous pathology of sIBM were analyzed. Myoblasts from three sIBM cases and six controls were differentiated into myotubes. In the RNA-sequencing analysis of these "myotube" samples, 104 differentially expressed genes (DEGs) were found to be significantly upregulated by more than twofold in sIBM, and 13 DEGs were downregulated by less than twofold. For muscle biopsy samples, a comparative analysis was conducted to determine the extent to which "biopsy" and "myotube" samples differed. Fifty-three DEGs were extracted of which 32 (60%) had opposite directions of expression change (e.g., increased in biopsy vs decreased in myotube). Apolipoprotein E (apoE) and transmembrane protein 8C (TMEM8C or MYMK) were commonly upregulated in muscle biopsies and myotubes from sIBM. ApoE and myogenin protein levels were upregulated in sIBM. Given that enrichment analysis also captured changes in muscle contraction and development, the triggering of muscle atrophy signaling and abnormal muscle differentiation via MYMK or myogenin may be involved in the pathogenesis of sIBM. The presence of DEGs in sIBM suggests that the myotubes formed from sIBM-derived myoblasts revealed the existence of muscle cell-autonomous degeneration in sIBM. The catalog of DEGs will be an important resource for future studies on the pathogenesis of sIBM focusing on primary muscle degeneration.

Identifiants

pubmed: 39088432
doi: 10.1371/journal.pone.0306021
pii: PONE-D-24-02730
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0306021

Informations de copyright

Copyright: © 2024 Suzuki et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Naoki Suzuki (N)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Department of Rehabilitation Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Makoto Kanzaki (M)

Graduate School of Biomedical Engineering, Tohoku University, Sendai, Japan.

Masashi Koide (M)

Department of Orthopedic Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan.

Rumiko Izumi (R)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Ryo Fujita (R)

Department of Orthopedic Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan.

Tadahisa Takahashi (T)

Department of Orthopedic Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan.

Kazumi Ogawa (K)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Department of Orthopedic Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan.

Yutaka Yabe (Y)

Department of Orthopedic Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan.

Masahiro Tsuchiya (M)

Department of Nursing, Tohoku Fukushi University, Sendai, Japan.

Masako Suzuki (M)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Ryuhei Harada (R)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Akiyuki Ohno (A)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Hiroya Ono (H)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Department of Neurology, National Hospital Organization Iwate Hospital, Ichinoseki, Iwate, Japan.

Naoko Nakamura (N)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Kensuke Ikeda (K)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Hitoshi Warita (H)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Shion Osana (S)

Division of Biomedical Engineering for Health and Welfare, Graduate School of Biomedical Engineering, Tohoku University, Sendai, Japan.

Yoshitsugu Oikawa (Y)

Department of Pediatrics, Tohoku University Graduate School of Medicine, Sendai, Japan.
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Takafumi Toyohara (T)

Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Department of Medical Science, Tohoku University Graduate School of Biomedical Engineering, Sendai, Japan.

Takaaki Abe (T)

Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Department of Medical Science, Tohoku University Graduate School of Biomedical Engineering, Sendai, Japan.
Department of Clinical Biology and Hormonal Regulation, Tohoku University Graduate School of Medicine, Sendai, Japan.

Muliang Rui (M)

Department of Rehabilitation Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Satoru Ebihara (S)

Department of Rehabilitation Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Ryoichi Nagatomi (R)

Division of Biomedical Engineering for Health and Welfare, Graduate School of Biomedical Engineering, Tohoku University, Sendai, Japan.

Yoshihiro Hagiwara (Y)

Department of Orthopedic Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan.

Masashi Aoki (M)

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH